Health plans and Medicare Advantage: regulatory and accreditation changes
This page collects dated changes for health plans: Medicare Advantage and Part D announcements, Federal Register rules on Marketplace plans and agents and brokers, and accreditor items on plan programs. Each entry quotes or reports one sentence from the authority's page, links to it, and adds the effective date or comment deadline when the source states one. Entries from accreditors whose terms limit reuse show title, date and link only. IHS prepares health plans for URAC accreditation (NCQA accreditation work is led by Maureen Plumstead) and supports CMS program audit readiness and compliance programs, so these items are part of the record IHS reads each day. The entries report what the authorities published; they do not interpret it, and the linked source is the original wording.
Related IHS services: Medicare Advantage and Part D Compliance Program and FDR Oversight Consulting · URAC Medicare Advantage Organization Accreditation Consulting
Last checked: . 1 entries.
· Centers for Medicare & Medicaid Services
Medicare Advantage & Medicare Prescription Drug Programs Expected to Remain Stable in 2027
Centers for Medicare & Medicaid Services states: “CMS announced significant premium savings for millions of Medicare beneficiaries in 2027, with weighted average Medicare Advantage (MA) premiums projected to fall more than 16% from 2026 to 2027, and average prescription drug premiums in MA projected to plummet 38%. Additionally, the average premium for stand-alone Part D prescription drug plans is projected to rise by less than $1 per month in 2027.”
Related IHS services: Medicare Advantage and Part D Compliance Program and FDR Oversight Consulting · URAC Medicare Advantage Organization Accreditation Consulting
Checked
All accreditors, agencies and topics: Standards changes. Entries quote or report what the authorities published; they are not legal advice and do not interpret the changes.